Gershman Boris, Ernandez John, Kaul Sumedh, Perez-Londoño Agustin, Fleishman Aaron, Korets Ruslan, Chang Peter, Wagner Andrew A, Kim Simon, Bellmunt Joaquim, Aghdam Nima, McCarthy Ellen P, Kim Dae Hyun, Olumi Aria F
Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA.
Department of Urology, Brigham and Womens Hospital, Boston, MA.
Urol Oncol. 2025 Sep;43(9):521.e9-521.e17. doi: 10.1016/j.urolonc.2025.04.009. Epub 2025 May 27.
Frailty is increasingly recognized as an important component of geriatric assessment in older adults and an important predictor of clinical outcomes. Bladder cancer (BC) is a potentially lethal disease, and treatments like radical cystectomy (RC) are associated with high rates of morbidity. We examined the associations of baseline frailty with perioperative outcomes and survival in a population-based cohort of older adults undergoing RC.
We identified older adults aged 66 to 89 years with Tany Nany cM0 urothelial carcinoma of the bladder who underwent RC from 2000 to 2017 in SEER-Medicare. Baseline frailty was assessed using the claims-based frailty index (CFI), a validated deficit accumulation frailty measure, within the 12-months preceding surgery. The associations of CFI with perioperative outcomes and survival were evaluated using multivariable regression models.
A total of 6,041 patients were included in the study cohort, including 2,640 (44%) who were robust (CFI <0.15), 2,980 (49%) who were prefrail (CFI 0.15-<0.25), and 421 (7%) who were mildly to severely frail (CFI ≥0.25). Increasing CFI was associated with statistically significantly higher rates of prolonged hospitalization, 90-day emergency department utilization, 90-day complications, and 90-day hospital readmission, and fewer healthy days at home (HDAH). CFI remained independently associated with an increased risk of perioperative outcomes and worse mortality in multivariable regression models.
In a national, contemporary cohort of older adults with BC undergoing RC, increasing frailty was independently associated with a higher risk of perioperative morbidity, fewer HDAH, and worse mortality. The CFI provides an objective assessment to improve decision-making in older adults with bladder cancer.
衰弱日益被视为老年评估的重要组成部分,也是临床结局的重要预测指标。膀胱癌(BC)是一种潜在致命疾病,根治性膀胱切除术(RC)等治疗方法的发病率很高。我们研究了基于人群的接受RC的老年队列中基线衰弱与围手术期结局及生存的关联。
我们在SEER-Medicare中识别出2000年至2017年期间接受RC的66至89岁的膀胱TaNxM0尿路上皮癌老年患者。在手术前12个月内,使用基于索赔的衰弱指数(CFI)评估基线衰弱情况,CFI是一种经过验证的缺陷累积衰弱测量方法。使用多变量回归模型评估CFI与围手术期结局及生存的关联。
研究队列共纳入6041例患者,其中2640例(44%)为健康状态(CFI<0.15),2980例(49%)为衰弱前期(CFI 0.15-<0.25),421例(7%)为轻度至重度衰弱(CFI≥0.25)。CFI升高与住院时间延长、90天急诊科就诊率、90天并发症发生率、90天再入院率的统计学显著升高以及在家健康天数(HDAH)减少相关。在多变量回归模型中,CFI仍然与围手术期结局风险增加和死亡率恶化独立相关。
在全国性的当代接受RC的老年BC患者队列中,衰弱程度增加与围手术期发病率较高、HDAH较少以及死亡率较差独立相关。CFI为改善老年膀胱癌患者的决策提供了客观评估。